The Cost-Effectiveness Of Delayed Release Dimethyl Fumarate Versus Glatiramer Acetate For The Treatment Of Relapsing-Remitting Multiple Sclerosis In The Mexican Social Security Institute (Imss)
Autor: | P Anaya, JA de Anda, M Machado, P Serafini, C Noda, A Azamar |
---|---|
Rok vydání: | 2016 |
Předmět: |
Oncology
medicine.medical_specialty Dimethyl fumarate Cost effectiveness business.industry Health Policy Multiple sclerosis Public Health Environmental and Occupational Health Delayed release (linguistics) medicine.disease chemistry.chemical_compound Relapsing remitting chemistry Internal medicine Immunology medicine Glatiramer acetate business medicine.drug |
Zdroj: | Value in Health. 19:A432 |
ISSN: | 1098-3015 |
Databáze: | OpenAIRE |
Externí odkaz: |